biotechnology Archives – Cambridge Enterprise

BioTryp Therapeutics Raises Pre Seed Funding - anti-biofilm

BioTryp Therapeutics raises pre-seed funding to advance its novel biofilm-inhibiting technology

Morphogen-IX News 27 Nov 18

Spin-out Morphogen-IX raises £18.4m in a Series B financing

18 December 2018

Spin-out Morphogen-IX announces its clinical development candidate

27 November 2018

Seed Fund Investment Manager on BioBeat’s 2018 list of 50 Female Movers and Shakers

01 November 2018

Cambridge Enterprise licenses IP to produce platelets from stem cells

15 December 2016

Holographic diagnostics developed to monitor medical conditions

23 January 2014

Clearing the BAR to oral vaccines

Commercialising medical device innovation

New programme to help Cambridge researchers connect with industry

TeraView strengthens relationship with Cambridge University

22 February 2011

Cambridge spin-outs recognised at European entrepreneurship awards

04 February 2011

Astex announces milestone in oncology collaboration

12 January 2011